Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-008453
Filing Date
2017-08-09
Accepted
2017-08-09 15:43:18
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fcsc-201763010q.htm 10-Q 935322
2 EXHIBIT 31 fcsc-2017630ex31.htm EX-31 9841
3 EXHIBIT 32 fcsc-2017630ex32.htm EX-32 6904
10 fcsccolorlogoa01.jpg GRAPHIC 74382
11 pipelinepicture2.jpg GRAPHIC 86063
  Complete submission text file 0001628280-17-008453.txt   5544546

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fcsc-20170331.xml EX-101.INS 1085582
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20170331.xsd EX-101.SCH 40998
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20170331_cal.xml EX-101.CAL 58476
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fcsc-20170331_lab.xml EX-101.LAB 557426
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20170331_pre.xml EX-101.PRE 350987
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20170331_def.xml EX-101.DEF 234817
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 171017727
SIC: 2834 Pharmaceutical Preparations